Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
Body unavailable. Use the original source.
Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.